The management of non-small cell lung cancer (NSCLC) is evolving significantly, as recent presentations reveal a shift toward the incorporation of protein-based biomarkers and computational techniques....
Dr. Ghayas C. Issa, a prominent clinical and translational researcher at The University of Texas MD Anderson Cancer Center, has outlined essential strategies for genetic testing...
